Compounds > garenoxacin
Page last updated: 2024-09-03

garenoxacin and Mycoplasma dispar Infection

garenoxacin has been researched along with Mycoplasma dispar Infection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hosono, H; Ishida, T; Izumikawa, K; Kohno, S; Kushimoto, S; Miyashita, N; Watanabe, A1
Fukushima, K; Hayama, Y; Ikeda, T; Nakatsubo, M; Niju, T; Noda, M; Oniki, S; Saito, Y; Tsuruta, N; Uenami, T1

Other Studies

2 other study(ies) available for garenoxacin and Mycoplasma dispar Infection

ArticleYear
Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: postmarketing surveillance in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Product Surveillance, Postmarketing; Prospective Studies; Quinolines; Tablets

2014
Anaphylaxis due to intravenous levofloxacin with tolerance to garenoxacin.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:13

    Topics: Adult; Anaphylaxis; Anti-Bacterial Agents; Cross Reactions; Drug Hypersensitivity; Fluoroquinolones; Humans; Injections, Intravenous; Levofloxacin; Male; Ofloxacin; Pneumonia, Mycoplasma; Skin Tests

2012